Singapore markets open in 44 minutes

Koninklijke Philips N.V. (PHG)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
20.38-0.16 (-0.78%)
At close: 04:00PM EST
20.38 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous close20.54
Bid20.09 x 3200
Ask20.68 x 4000
Day's range20.30 - 20.44
52-week range12.96 - 23.30
Avg. volume1,133,171
Market cap18.74B
Beta (5Y monthly)0.79
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date12 May 2022
1y target estN/A
  • Zacks

    Philips (PHG) Adds Smart Fit Coils to Boost Diagnostic Imaging

    Philips (PHG) launches three MR Smart Fit coils, namely TorsoCardiac 1.5T, 1.5T shoulder and Knee 3.0T, enhancing flexibility, reducing patient setup time and improving image quality resolution.

  • Yahoo Finance Video

    Royal Philips CEO talks device recall, AI

    Royal Philips's (PHG) strategic transformation from consumer electronics to healthcare innovation is well underway. The company's goal is to improve the lives of three billion people a year by 2025. But the transition has been a bumpy ride for investors. Shares of the Dutch manufacturer have slumped amid a recall of its sleep apnea devices. Royal Philips CEO Roy Jakobs joins Yahoo Finance Live to discuss the recalls as well as the company's measured adoption of AI-powered solutions. "We do it in a responsible manner... The National Academy of Medicine has gathered tech companies, providers, regulators and government officials to develop a code of conduct for responsible AI application," Jakobs said. "AI can come to the rescue but, of course, you need to be aware of what it can and cannot do." Jakobs added: "The closer you get to the patient, the more careful you need to be." Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here.

  • Financial Times

    Philips: suspect device prompts night terrors for investors

    Dutch medical equipment group Philips hardly qualifies. Devices to manage sleep disorders are giving its shareholders nightmares. The machines are meant to help sleep apnoea sufferers breathe easily at night.